Literature DB >> 16643362

Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction.

Petri Korhonen1, Terhi Husa, Ilkka Tierala, Heikki Väänänen, Markku Mäkijärvi, Toivo Katila, Lauri Toivonen.   

Abstract

INTRODUCTION: Increased intra-QRS fragmentation score (FRA) in magnetocardiography (MCG) has shown association with sustained ventricular arrhythmias in post-MI patients suggesting its relation to arrhythmia substrate. The aim of this study was to investigate whether increased FRA in MCG predicts arrhythmic events and mortality after acute myocardial infarction (MI) with cardiac dysfunction. METHODS AND
RESULTS: A series of 158 patients with acute MI and left ventricular ejection fraction (LVEF) <50% were studied. Their age was 60 +/- 10 years and LVEF 40 +/- 6%. MCG was registered and FRA was computed. For comparison, QRS duration in 12-lead ECG was measured. In a mean follow-up of 50 +/- 15 months, 32 (20%) patients died and 18 (11%) had an arrhythmic event. Both arrhythmic event rate and all-cause mortality were significantly higher in patients with increased FRA (P < 0.001 for both). In contrast, increased QRS duration in ECG predicted all-cause mortality (P < 0.05) but not arrhythmic events. In multivariate analysis, FRA was an independent predictor of both arrhythmic events and all-cause mortality. Using a combined criterion of increased FRA and LVEF < 30% yielded positive and negative predictive accuracies of 50% and 91% for arrhythmic events.
CONCLUSION: In post-MI patients with left ventricular dysfunction, increased intra-QRS fragmentation in high-resolution magnetocardiography predicts arrhythmic events, whereas QRS duration in 12-lead ECG predicts all-cause mortality. Analysis of intra-QRS fragmentation by MCG may assist in guiding therapy of post-MI patients, for example, by selecting those who would benefit most from prophylactic implantable cardioverter-defibrillator therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16643362     DOI: 10.1111/j.1540-8167.2005.00332.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  7 in total

Review 1.  [Limitations and possibilities of noninvasive risk stratification for sudden cardiac death].

Authors:  Tobias Tönnis; Karl-Heinz Kuck
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

2.  Optical multichannel room temperature magnetic field imaging system for clinical application.

Authors:  G Lembke; S N Erné; H Nowak; B Menhorn; A Pasquarelli
Journal:  Biomed Opt Express       Date:  2014-02-25       Impact factor: 3.732

3.  Prognostic value of electromagnetic QRS fragmentation in survivors of sustained ventricular tachycardia or ventricular fibrillation compared with healthy controls.

Authors:  Thomas Kleemann; Kleopatra Kouraki; Margit Strauss; Alexandros Skarlos; Uwe Zeymer; Ralf Zahn
Journal:  J Interv Card Electrophysiol       Date:  2012-11-20       Impact factor: 1.900

4.  A patient with severely reduced LV function and electrical storm saved by wearable cardioverter-defibrillator: a case report.

Authors:  Margit Strauss; Kleopatra Kouraki; Alexandros Skarlos; Ralf Zahn; Thomas Kleemann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-06

5.  Repolarization Heterogeneity of Magnetocardiography Predicts Long-Term Prognosis in Patients with Acute Myocardial Infarction.

Authors:  Woo Dae Bang; Kiwoong Kim; Yong Ho Lee; Hyukchan Kwon; Yongki Park; Hui Nam Pak; Young Guk Ko; Moonhyoung Lee; Boyoung Joung
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

6.  Fragmented QRS: What Is The Meaning?

Authors:  Yutaka Take; Hiroshi Morita
Journal:  Indian Pacing Electrophysiol J       Date:  2012-09-01

7.  MAGNETO cardiography parameters to predict future Sudden Cardiac Death (MAGNETO-SCD) or ventricular events from implantable cardioverter defibrillators: study protocol, design and rationale.

Authors:  Thomas Lachlan; Hejie He; Kavi Sharma; Jamal Khan; Kim Rajappan; Adrian Morley-Davies; Ashish Patwala; Harpal Randeva; Faizel Osman
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.